Uganda has been put on spot for not fully utilizing the research and science it has been part of to help curb the HIV/AIDS epidemic among affected populations.

Bharam Namanya, the Executive Director, Community Health Alliance-Uganda (CHAU) says it is only when Uganda fully implements the science that has been approved by the global health platforms.

“It’s only when Uganda  can fully utilize research findings that are globally recommended that will enable it  to drastically reduce the numbers of new HIV infections as well as reduce on the numbers of those having the disease not to transmit it to those living a negative life,” he says.

Namanya further notes that the ministry of health has not implemented the globally accepted and revised HIV treatment guidelines which require governments to put all HIV positive clients on treatment no matter their HIV status.

Staff members of CHAU

CHAU is a local NGO that advocates for people living with HIV/AIDs in Uganda.

He further raises concerns over the over inflation of ARVs by Quality Chemical Industries which she says is over 36% when compared to the global market prices saying these are among the factors that have seen the Country get many HIV clients off treatment due to consistent drug stock outs as government cannot fully afford to procure the drugs.
Currently 1.5m Ugandans are living with HIV and only 749,308 are on ARVs.
Meanwhile Communities living with HIV are asking the health ministry to think of implementing PREP guidelines to make it easy for the communities to access HIV transmission preventive treatment from health facilities.

With the Country not implementing these guidelines, it makes it very hard for anyone whose fears that he or she has contracted HIV through conditions that he or she didn’t feel comfortable to access PREP. It is a kind of treatment given to a person suspecting to have contracted HIV with in the fast 48 hours may be through rape, accidents among others channels

Namanya however,  says this will remain a dream if the Ugandan government continues to bypass these global regulations.